The questions that were posed to the biopharmaceutical industry in 2020 were more urgent than ever before, as the COVID-19 pandemic brought much of the world to 27 October 2022
Talking the talk alone is no longer enough for pharma companies where their digital strategies are concerned—now they need to walk the walk, too. 24 October 2022
In August, UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Sunlenca (lenacapavir) injection and tablets, alongside other antiretrovirals, in adu 21 October 2022
Since the outbreak of the COVID-19 pandemic, the Egyptian government has offered tremendous opportunities for the localization of the vaccine and biologics’ ind 17 October 2022
The challenges of tackling international crime with national law enforcement are legion.writes John Binns.partner in the Financial Crime team at BCL Solicitors. 17 October 2022